List of articles with "Novartis"

FDA Approves Itvisma

FDA Approves Itvisma

USA SMA Novartis East Hanover Itvisma
Victor Bulto at Labcorp

Victor Bulto at Labcorp

USA Burlington Labcorp Novartis Victor Bulto
Avidity Q3 2025 Update

Avidity Q3 2025 Update

USA San Diego RNA Therapeutics Novartis Avidity Biosciences
Avidity Inquiry

Avidity Inquiry

USA Milwaukee Novartis Avidity Biosciences Ademi Firm
Novartis Acquires Avidity

Novartis Acquires Avidity

United States San Diego RNA Therapeutics Novartis Avidity Biosciences
NCCN Funding for Breast Cancer

NCCN Funding for Breast Cancer

United States Breast Cancer Plymouth Meeting Novartis NCCN
Rhapsido® Approval

Rhapsido® Approval

None Novartis CSU Rhapsido
Max Foundation's Cancer Care Vision

Max Foundation's Cancer Care Vision

USA New York Novartis Cancer Care Max Foundation
Kesimpta® Success in MS

Kesimpta® Success in MS

United States Multiple Sclerosis Novartis East Hanover Kesimpta
Argo and Novartis Deal

Argo and Novartis Deal

China Shanghai Cardiovascular Novartis Argo Biopharma
BioArctic Update

BioArctic Update

Sweden Stockholm Leqembi BioArctic Novartis
BioArctic Q2 Report

BioArctic Q2 Report

Sweden Stockholm Leqembi BioArctic Novartis
BioArctic Novartis Deal

BioArctic Novartis Deal

Sweden Stockholm BioArctic Novartis BrainTransporter
BioArctic and Novartis Deal

BioArctic and Novartis Deal

Sweden Stockholm BioArctic Novartis BrainTransporter
Ianalumab Trials Success

Ianalumab Trials Success

United States Novartis East Hanover Sjögren's Disease Ianalumab
Leqvio FDA Approval

Leqvio FDA Approval

USA FDA Approval Novartis East Hanover LEQVIO
Sironax & Novartis

Sironax & Novartis

USA Waltham Novartis Sironax Brain Delivery
Sironax and Novartis Partnership

Sironax and Novartis Partnership

USA Waltham Novartis Sironax Brain Delivery
Cosentyx GCA Study Results

Cosentyx GCA Study Results

United States Novartis East Hanover, NJ Cosentyx GCAptAIN
Regulus and Novartis Deal

Regulus and Novartis Deal

USA San Diego Regulus Therapeutics Novartis farabursen
FABHALTA Disruption

FABHALTA Disruption

United States Las Vegas Novartis Fabhalta iptacopan
Revolutionizing IgA Nephropathy

Revolutionizing IgA Nephropathy

United States Las Vegas IgA nephropathy Novartis Vanrafia
Novartis Expands US Operations

Novartis Expands US Operations

United States Novartis East Hanover, NJ Research Hub US Investment
FDA Approval for Pluvicto®

FDA Approval for Pluvicto®

United States Novartis East Hanover Prostate Cancer Pluvicto®
Novartis AAN Findings

Novartis AAN Findings

USA San Diego Novartis MS Research Kesimpta
Novartis' Fabhalta Approval

Novartis' Fabhalta Approval

USA Novartis East Hanover Fabhalta C3G
Novartis Immunology Highlights

Novartis Immunology Highlights

USA Novartis East Hanover Hidradenitis Suppurativa CSU
Novartis Wins Super Bowl Ad

Novartis Wins Super Bowl Ad

USA Advertising Super Bowl Novartis Evanston
Cora BC App Launch

Cora BC App Launch

Denmark Copenhagen Novartis Dawn Health Cora BC
Cora BC Launch

Cora BC Launch

Denmark Copenhagen Novartis Dawn Health Cora BC
Cora BC for Breast Cancer

Cora BC for Breast Cancer

Denmark Copenhagen Novartis Dawn Health Cora BC
Cora BC Launched

Cora BC Launched

None Novartis Dawn Health Cora BC
Breast Health Awareness

Breast Health Awareness

United States Breast Cancer Novartis East Hanover Wanda Sykes
Kisqali Breakthrough Data

Kisqali Breakthrough Data

USA Breast Cancer Novartis East Hanover Kisqali
Max & Novartis Partner

Max & Novartis Partner

USA Seattle Novartis Max Foundation Fabhalta
Collaboration on Huntington's Disease

Collaboration on Huntington's Disease

United States PTC Therapeutics Warren, New Jersey Novartis Huntington's Disease

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.